These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32194037)

  • 1. Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS.
    Liu X; Gao X; Zhang R; Liu Z; Shen N; Di Y; Fang T; Li H; Tian F
    Clin Biochem; 2020 Aug; 82():40-50. PubMed ID: 32194037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential plasma biomarkers and metabolic dysfunction for unstable angina pectoris and its complication based on global metabolomics.
    Wang J; Xu W; Zhao H; Chen J; Zhu B; Li X; Deng D; Wang J; Liu J; Yu Y; Xiao H; Wang W
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30770400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
    Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
    Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
    Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS.
    Liu T; Li J; Xu F; Wang M; Ding S; Xu H; Dong F
    Anal Bioanal Chem; 2016 Feb; 408(4):1125-35. PubMed ID: 26677023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
    He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
    Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipid Metabolite Profiling of Acromegaly.
    Wang M; Guo S; He M; Shao X; Feng L; Yu Y; Gong W; Liu Q; Melnikov V; Wang X; He Z; Jiang L; Chen M; Sun J; Cai J; Zhao Y; Li Y; Tritos NA; Hu Z; Zhang Z
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31930294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort.
    Wang H; Wang Y; Li X; Deng X; Kong Y; Wang W; Zhou Y
    Cardiovasc Diabetol; 2022 Dec; 21(1):288. PubMed ID: 36564831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-mass spectrometry untargeted metabolomics reveals increased levels of tryptophan indole metabolites in urine of metabolic syndrome patients.
    Esperanza MG; Wrobel K; Ojeda AG; Garay-Sevilla ME; Escobosa ARC; Barrientos EY; Wrobel K
    Eur J Mass Spectrom (Chichester); 2020 Dec; 26(6):379-387. PubMed ID: 33295818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolomics study of Danggui Buxue Tang on treatment of type 2 diabetes mice using UHPLC-Q-TOF-MS].
    Sun LL; Bai HY; Zheng WH; Wang LY; Zhao W; Li JY; Shi YB; Yang ZG
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):636-644. PubMed ID: 32237524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach.
    Jing Z; Liu L; Shi Y; Du Q; Zhang D; Zuo L; Du S; Sun Z; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():692893. PubMed ID: 34630321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia.
    Zhang Y; Zhang H; Rong S; Bian C; Yang Y; Pan H
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2449-2457. PubMed ID: 34154888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
    Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
    Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment.
    Chen R; Zeng Y; Xiao W; Zhang L; Shu Y
    Front Endocrinol (Lausanne); 2021; 12():665309. PubMed ID: 34276557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics study of serum and urine samples reveals metabolic pathways and biomarkers associated with pelvic organ prolapse.
    Deng W; Rao J; Chen X; Li D; Zhang Z; Liu D; Liu J; Wang Y; Huang O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121882. PubMed ID: 31809960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
    Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
    J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
    Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
    Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic analysis reveals potential biomarkers and serum metabolomic profiling in spontaneous intracerebral hemorrhage patients using UPLC/quadrupole time-of-flight MS.
    Sun G; Jiang F; Hu S; Cheng H; Qu L; Tao Y; Ma B
    Biomed Chromatogr; 2022 Jan; 36(1):e5241. PubMed ID: 34505712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.